Stories from people navigating atherosclerotic cardiovascular disease — diagnosis, treatment, caregiving, and the ordinary days in between.
3 stories
Cardiology
In AMUNDSEN, evolocumab started before PCI rapidly lowered LDL cholesterol after acute myocardial infarction but did not improve clinical outcomes at 1 year.
Rayan Salih · October 19, 2026 · 7 min
Endocrinology & Metabolism
SELECT found fewer major cardiovascular events with semaglutide among adults with overweight or obesity, established cardiovascular disease and no diabetes.
Rayan Salih · 6 min read
Health Policy
The 2026 joint guideline links lipid management to CKM stage and PREVENT-ASCVD risk, with explicit LDL-C, non-HDL-C and apoB goals for US adults.
Rayan Salih · 7 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.